Fatty acids are thought to play a role in the activity of uncoupling proteins (UCP) and have been shown to regulate the expression of genes encoding proteins involved in fatty acid handling. Therefore, we investigated whether fatty acids, which are the main substrates for the heart, affect rat cardiac UCP-2 expression in vivo and in vitro. After birth, when the contribution of fatty acid oxidation to cardiac energy conversion increases, UCP-2 expression enhanced rapidly. In the adult heart, however, UCP-2 mRNA levels did not alter during conditions associated with either enhanced (fasting, diabetes) or decreased (hypertrophy) fatty acid utilization. Exposure of neonatal cardiomyocytes and embryonic rat heart-derived H9c2 cells to fatty acids (palmitic and oleic acid) for 48 h strongly induced UCP-2 expression. Stimulation of neonatal cardiomyocytes with triiodothyronine also increased UCP-2 mRNA levels, though only in the presence of fatty acids. Ligands specific to the fatty acid-activated transcription factor PPAR␣, but not to PPAR␥, acted as inducers of cardiomyocyte UCP-2 expression. It is concluded that fatty acids promote UCP-2 expression in neonatal cardiomyocytes, which might explain the rapid increase in UCP-2 mRNA in the postnatal heart. However, UCP-2 mRNA levels in the adult heart appear to be insensitive to changes in cardiac fatty acid handling under various pathological conditions.-van der Lee, K. A. J. M., Willemsen, P. H. M., van der Vusse, G. J., van Bilsen, M. Effects of fatty acids on uncoupling protein-2 expression in the rat heart. FASEB J. 14, 495-502 (2000) 
Besides being the main source of energy for the heart, fatty acids were also found to act as uncouplers of oxidative phosphorylation. Pioneering studies by Challoner and Steinberg (1) have shown that fatty acids increase cardiac oxygen consumption for the same amount of external work when applied to the isolated perfused rat heart. This indicates uncoupling of mitochondrial respiratory chain activity and ATP production. Later studies demonstrated progressive uncoupling in heart mitochondria when rats were fed a lipid-enriched diet (2) .
The uncoupling protein (UCP) is known to uncouple oxidative phosphorylation by moving protons across the mitochondrial inner membrane toward the mitochondrial matrix (reviewed in ref 3) . Whereas the first uncoupling protein (UCP-1) was reported two decades ago, two other members of the family (i.e., UCP-2 and -3) have recently been cloned (4 -6) . UCP-3 is expressed mainly in brown adipose tissue and skeletal muscle, whereas UCP-2 is more ubiquitously distributed. Since expression of UCP-2 is relatively high in heart tissue (4, 5) , it is feasible that UCP-2 mediates the fatty acid-induced uncoupling effects observed in this organ. Indeed, fatty acids have been demonstrated to enhance the uncoupling activity of UCP (7) . Therefore, we propose a close functional relationship between fatty acid handling and uncoupling proteins in cardiac tissue.
Recently we demonstrated in neonatal cardiomyocytes that fatty acids regulate the expression of genes encoding proteins involved in fatty acid transport and metabolism (8) . Other studies suggested that fatty acids may also be implicated in the regulation of UCP-2 expression. For instance, skeletal muscle UCP-2 mRNA levels in rat and human were found to increase during fasting, a condition associated with a rise in plasma fatty acid levels (9 -11) . Subsequent refeeding of rats resulted in a decline in plasma fatty acid levels and a concomitant decrease in skeletal muscle UCP-2 expression (11) .
The first aim of the present study was to investigate whether cardiac UCP-2 mRNA levels change during heart development and under (patho)physiological conditions associated with changes in fatty acid utilization in the adult heart, i.e., fasting, diabetes and cardiac hypertrophy. Second, it was determined whether UCP-2 expression is up-regulated in cultured neonatal cardiomyocytes and embryonic rat heart-derived H9c2 cells after exposure to fatty acids and/or after stimulation with the ␣ 1 -adrenergic agonist phenylephrine or the thyroid hormone triiodothyronine (T3). Finally, the possible involvement of peroxisome proliferatoractivated receptors (PPARs), transcription factors known to be activated by fatty acids (12, 13) , in neonatal cardiomyocyte UCP-2 expression was explored.
MATERIALS AND METHODS

Animal experiments
Animals were fed ad libitum (Diet SRIVI-A, Hope Farms, Woerden, the Netherlands), had free access to water, and were kept under an artificial dark-light cycle of 12 h. The experiments were approved by the Institutional Animal Care and User Committee of the Maastricht University.
Heart, soleus, extensor digitorum longus (EDL), and gastrocnemius muscles were dissected from adult (10-wk-old) Wistar Kyoto rats. Hearts were also obtained at birth (day 0) and at 2, 6, and 21 days. Hearts from fetal rats were obtained by killing pregnant rats, on day 21 of pregnancy (day 1).
Insulin-dependent diabetes was evoked in 3-month-old male Wistar rats (Winkelmann, Borchen, Germany) by a single intravenous (i.v.) injection of streptozotocin (55 mg/kg body weight) as described elsewhere (14) . Rats were killed after 3 wk, when body weight had decreased by 27% and plasma glucose levels had increased from 7.0 Ϯ 0.7 mM to 22.5 Ϯ 2.7 mM (14) .
Cardiac hypertrophy was induced by suprarenal aorta banding as described previously (15) . After anesthetization of 6-or 7-wk-old male Lewis rats with pentobarbital (0.06 mg/g body weight i.p.), a lateral abdominal incision was made. In the experimental group, a ligature was tightened suprarenally around the abdominal aorta. In sham-operated animals, the aorta was only dissected free. The abdomen was closed and the rats were allowed to recover. After 4 wk animals were killed and mean heart to body weight ratio had increased by 24%.
Hearts of 6-wk-old male Sprague-Dawley rats, either fasted for 46 h or fed ad libitum, were a generous gift from Dr. S. Samec and Dr. A. Dulloo, University of Geneva, Switzerland. In the serum of fasted rats, fatty acid levels had increased threefold (1.33Ϯ0.25 mM vs. 0.45Ϯ0.13 mM) at the time of death (16) .
Rats subjected to the different treatments were killed by cervical dislocation, except for rats previously subjected to sham or aorta banding operations whose hearts were excised after anesthesia with pentobarbital (0.06 mg/g body weight i.p.). After excision, tissues were immediately frozen in liquid nitrogen and stored at Ϫ80°C until further analysis.
Cell culture
Primary cultures of ventricular myocytes from 0-to 3-day-old neonatal rats were prepared as described previously (17) . Cardiomyocytes were plated at low density (40,000 cells/cm 2 ) in tissue culture dishes coated with 1% gelatin type B (Sigma, St. Louis Mo.) in a 4:1 mixture of DMEM (Life Technologies, Inc.-BRL, Gaithersburg, Md.) and M199 (Life Technologies) supplemented with 10% horse serum (Life Technologies), 5% newborn calf serum (Sera-Lab, Sussex, U.K.), and antibiotics (P/S; penicillin 100 IU/ml and streptomycin 0.1 mg/ml, Life Technologies). Cells were incubated overnight in this serum-rich medium.
H9c2 cells (ATCC CRL-1446; Rockville, Md.) were maintained in a growth medium composed of DMEM supplemented with 10% fetal bovine serum (Life Technologies). Medium was changed every 3 to 4 days. H9c2 cells were plated at a density of 2000 cells/cm 2 and allowed to proliferate in growth medium until reaching confluency.
Experiments with neonatal cardiomyocytes as well as H9c2 cells started with a 24 h incubation in serum-free medium of a 4:1 mixture of DMEM/M199, containing P/S and 10 mM glucose as the sole substrate. Subsequently, substrate-free medium (4:1 mixture of DMEM and M199 with P/S) containing 0.25 mM l-carnitine and 0.25 mU/ml insulin was applied to the cells. This medium was supplemented with different substrates or a combination of substrates. The first experimental group received only glucose (final concentration, 10 mM) as substrate. Bovine serum albumin (BSA 0.15 mM; Sigma) was also added to the medium to allow for a proper comparison between the glucose group and the experimental groups, which received medium containing the fatty acid/ BSA complex. The second group received a mixture of palmitic acid (C16:0) and oleic acid (C18:1) (0.25 mM each, complexed to 0.15 mM BSA as described elsewhere; ref 17) . The third group received a combination of both substrates: glucose (10 mM) and C16:0/C18:1 (0.25 mM each). Cells were harvested after 48 h.
To induce in vitro hypertrophy, neonatal cardiac myocytes were stimulated with 10 M phenylephrine (PE; Sigma). In addition, neonatal cardiomyocytes were stimulated with 10 nM triiodothyronine (T3; Sigma). Both agents were added to the medium 48 h before harvesting.
Furthermore, 100 M Wy-14,643 (Biomol, Plymouth Meeting, Pa.) or 10 M ciglitazone (Biomol), specific ligands for PPAR␣ and PPAR␥, respectively, were added to neonatal cardiomyocytes 48 h prior to harvesting. The cardiomyocytes were cultured in medium containing glucose as the sole substrate. Both compounds were dissolved in DMSO to obtain a 1000ϫ stock solution.
Northern analysis
Total RNA was isolated with TRIzol reagent (Life Technologies). Ten or 20 g total RNA was size-fractionated on a denaturing gel (1% agarose, 5% formaldehyde, 1ϫ MOPS), transferred to a nylon membrane (Hybond-N, Amersham, Slough, U.K.) by capillary transfer, and fixed using standard techniques. After prehybridization, the filters were probed with a 0.9 kb EcoRI-SacI fragment of rat UCP-2 cDNA (kindly provided by Dr. D. Riquier, Center National de la Recherche Scientifique, Meudon, France), a 0.5 kb KpnI-BamHI fragment of mouse muscle-type carnitine palmitoyl transferase 1 (mCPT1; a gift of Dr. F. van de Leij, Rijksuniversiteit Groningen, the Netherlands), or a 1.5 kb XhoI-NcoI fragment of rat hexokinase II (HKII; kindly provided by Dr. E. Wilson, Michigan State University, East Lansing, Mich.). The cDNA probes were labeled with [␣-32 P]dCTP (3000 Ci/mmol; Amersham) by random priming (Radprime, Life Technologies) to a specific activity of Ͼ0.5 ϫ 10 9 cpm/g DNA. To correct for possible differences in transfer and loading, the filters were also hybridized with 32 P-labeled ribosomal 18S probe. After hybridization, filters were washed at the appropriate stringency to remove nonspecific binding. The filters were exposed to phosphor imaging screens, subsequently scanned with a PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.), and quantified using ImageQuant software (Molecular Dynamics).
Protein content and cell area
Total protein content of neonatal cardiomyocytes was quantified using the micro BCA method (Pierce, Rockford, Ill.) with BSA as standard. Cell area was assessed using Scion Image Software (http://scioncorp.com/) after monitoring with a CCD camera.
Statistics
Results are presented as mean percentage of the control group Ϯ sd. Comparison between two groups was performed with a two-tailed Student's t test for unpaired data. Comparison between multiple groups was performed with one-way analysis of variance (ANOVA). In case the F ratio obtained indicated that significant differences between groups were present, the Student's t test was carried out, applying Bonferroni's adjustment for multiple comparison (18) . Differences were considered significant at P Ͻ 0.05.
RESULTS
UCP-2 expression in different muscle types and during heart development
First, UCP-2 mRNA levels were determined in various striated muscle types of the rat. Figure 1 shows that expression of UCP-2 is relatively low in each of the skeletal muscle types examined, which are the fast-twitch glycolytic EDL, the slow-twitch oxidative soleus, and the fast-twitch glycolytic-oxidative gastrocnemius muscles. In contrast, expression of UCP-2 in cardiac muscle far exceeds UCP-2 mRNA levels in skeletal muscle, confirming that UCP-2 is abundantly expressed in the heart. Second, UCP-2 mRNA levels in heart tissue were determined during and after the perinatal period (Fig. 2) . In the fetal heart, expression of UCP-2 was rather low. At birth, when plasma fatty acid levels rise and cardiac fatty acid utilization increases (19) , UCP-2 mRNA levels increased threefold. Plateau levels were reached within 3 wk thereafter. In the adult heart, UCP-2 mRNA levels were approximately five times higher than before birth.
UCP-2 expression in the adult heart under (patho)physiological conditions
In the adult heart, fatty acid utilization changes under different (patho)physiological conditions. Whereas cardiac fatty acid utilization increases during fasting and diabetes (20, 21) , it decreases during cardiac hypertrophy (22) . To examine whether these changes are accompanied by alterations in the expression of UCP-2, UCP-2 mRNA levels were determined in hearts of fasted, diabetic, and aorta-banded rats. Fasting and streptozotocin-induced diabetes did not significantly alter the mRNA content of UCP-2 in the rat heart (Table 1) . Furthermore, in hypertrophied hearts of aorta-banded rats, expression of UCP-2 remained unchanged compared to hearts of sham-operated animals. To ascertain that the (patho)physiological conditions do affect the expression of genes involved in cardiac metabolism, the mRNA levels of the muscle-type carnitine palmitoyl transferase 1 (mCPT1) and hexokinase II (HKII) were also determined (Table 1) . Indeed, mCPT1 gene expression was increased during fasting and tended to decrease during cardiac hypertrophy (PϽ0.07), whereas HKII mRNA levels were significantly decreased or tended to decrease in all three conditions.
Fatty acid-induced expression of the UCP-2 gene in vitro
To examine whether expression of UCP-2 can be regulated by fatty acids, rat neonatal cardiomyocytes UCP-2 mRNA levels during rat heart development. The expression levels are relative to the mRNA levels at day 70. mRNA levels were first normalized to the corresponding 18S ribosomal RNA signal to correct for possible differences in loading.
and embryonic rat heart-derived H9c2 cells were used as in vitro cardiac model systems. Neonatal rat ventricular myocytes and H9c2 cells were cultured in the presence of glucose, fatty acids (palmitic acid and oleic acid), or a combination of both for 48 h. When neonatal cardiomyocytes were exposed to fatty acids, either in the absence or presence of glucose, UCP-2 expression increased Ͼeightfold as compared to cells receiving glucose as the sole substrate (Fig.  3) . In H9c2 cells, UCP-2 mRNA levels were also increased (Ͼfourfold) in the presence of fatty acids. As in vivo data suggested a relationship between serum insulin levels and UCP2 expression in white adipose tissue (23) and insulin was routinely added to the culture medium, it was also checked whether insulin affected fatty acid-induced UCP-2 expression in neonatal cardiomyocytes. In the absence and presence of different levels of insulin (0.025 and 0.25 mU/ml), fatty acids gave rise to a comparable increase (7-to 10-fold) of the UCP-2 mRNA content (data not shown).
Effects of phenylephrine and triiodothyronine on UCP-2 expression in vitro
To investigate whether an in vitro effect on UCP-2 expression could be found under hypertrophic conditions, neonatal cardiomyocytes were stimulated with the ␣ 1 -adrenergic agonist PE in the presence or absence of fatty acids for 48 h. Administration of PE (10 M) resulted in a 1.45 Ϯ 0.06 fold rise in cellular protein content. Mean cell area of ventricular myocytes increased from 91.3 Ϯ 15.0 m 2 to 129.6 Ϯ 15.1 m 2 . UCP-2 mRNA levels, however, were not affected by PE stimulation, irrespective of the substrate composition of the culture medium (Fig. 4) . In contrast, stimulation of the cells with the thyroid hormone T3 (10 nM) resulted in a twofold increased UCP-2 expression, though only in the presence of fatty acids.
Effects of PPAR ligands on UCP-2 expression in vitro
Next it was examined whether PPAR could be involved in the fatty acid-induced up-regulation of a Rats were fasted for 46 h, streptozotocin-treated for 3 wk, or aorta-banded for 4 wk. Uncoupling protein 2 (UCP-2), muscle-type carnitine palmitoyl transferase 1 (mCPT1) and hexokinase II (HKII) mRNA levels were normalized to the corresponding 18S ribosomal RNA signal to correct for possible loading differences. Data are presented as means Ϯ sd of three to five experiments. *Significantly different from control group (PϽ0.05). 
DISCUSSION
These data demonstrate that the mRNA levels of UCP-2, abundantly present in adult cardiac muscle, remain unchanged during fasting, diabetes, and hypertrophy, (patho)physiological conditions that are associated with changes in cardiac fatty acid utilization. However, cardiac UCP-2 gene expression is rapidly up-regulated during normal postnatal development. Moreover, in cultured neonatal rat cardiomyocytes and embryonic heart-derived H9c2 cells, fatty acids are found to induce UCP-2 expression, most likely through mechanisms involving transcription factors of the PPAR family.
UCP-2 expression in adult rat heart
During fasting and insulin-dependent diabetes, both plasma fatty acid levels and cardiac fatty acid oxidation increase in rats (20, 21, 24) . These conditions are associated with changes in the expression of various genes involved in cardiac metabolism, as reported previously for heart-type fatty acid binding protein (25, 26) and demonstrated for mCPT1 and HKII (see Table 1 ). In this respect, the absence of changes in cardiac UCP-2 mRNA levels is remarkable. In addition, cardiac hypertrophy, a condition associated with a decreased cardiac fatty acid oxidation (22) and concomitant down-regulation of the expression of genes involved in fatty acid metabolism (27) , does not affect UCP-2 expression either. The current findings are in line with recent observations by Hidaka and colleagues (28) , who demonstrated that both fasting and streptozotocin-induced diabetes results in enhanced UCP-3, but not UCP-2 mRNA levels, in the rat heart.
From the literature, the picture emerges that the regulation of UCP-2 expression in response to various stimuli is highly tissue dependent. Previously Samec et al. (16) reported that 46 h of fasting, which was associated with a threefold rise in serum fatty acid levels, led to increases in UCP-2 and UCP-3 expression in gastrocnemius, soleus, and tibialis anterior skeletal muscles. Likewise, liver UCP-2 mRNA levels are highly responsive to changes in diet (29) . Apparently, conditions that are associated with changes in plasma fatty acid levels and/or fatty acid utilization by the adult heart have no modulatory effect on adult cardiac UCP-2 expression. At present no satisfactory explanation can be provided for the behavior of UCP in different tissues. As for the heart, in which the expression of UCP-2 is very pronounced, it has been suggested (28) that the promoter of the UCP-2 gene is so active under basal conditions that an increase in its activity can hardly be detected. However, this notion is hard to reconcile with the observation that in vivo administration of T3 and cold exposure both increase cardiac UCP-2 expression in the rat (9, 30) . Furthermore, it does not explain why down-regulation of UCP-2 expression is never observed, for instance, under conditions that are associated with a reduction in cardiac fatty acid utilization, like cardiac hypertrophy.
UCP-2 expression increases in the perinatal period
Perinatally, a substantial rise in cardiac UCP-2 mRNA content was observed. In brown adipose tissue of mice, a marked increase of UCP-2 mRNA levels at birth has also been demonstrated (31) . However, in contrast to the UCP-2 expression pattern in the heart, UCP-2 mRNA levels in brown adipose tissue returned to fetal levels within 2 wk of birth (31) . It was suggested that the postnatal rise in UCP-2 expression might be caused by cold exposure of the newborn animal when delivered to the extra-uterine environment. The postnatal rise in circulating thyroid hormone levels (19) might also be responsible for the increase in UCP-2 expression after birth, since UCP-2 expression has been shown to be T3 responsive in isolated neonatal cardiomyocytes (see below; ref 32) and in the adult heart (30) . However, it should be kept in mind that nutritional factors also change during the perinatal period. Whereas the fetal diet consists mainly of carbohydrates, fat is the main component of the diet of suckling newborn animals (reviewed in ref 19) . During this period the heart also switches from carbohydrates to fatty acids as the main energy source (33) . Accordingly, it is tempting to speculate that the exposure to increased plasma fatty acid levels may be directly responsible for the increased UCP-2 mRNA levels. The current observation that fatty acids are able to enhance UCP-2 expression in neonatal cardiomyocytes seems to support this notion. On the other hand, manipulation of the diet directly after birth did not affect UCP-2 expression in skeletal muscle of mice (34) . In view of the tissue-specific behavior of uncoupling proteins, however, it remains to be established whether this also applies to UCP-2 gene expression in rat cardiac tissue.
Fatty acids enhance UCP-2 expression in vitro
Fatty acids were able to stimulate UCP-2 gene expression to a significant extent (up to 10-fold) in primary cultures of neonatal rat ventricular myocytes and in embryonic heart-derived H9c2 cells. To our knowledge such a direct effect of fatty acids on cardiac UCP-2 expression has never been demonstrated before. The fact that fatty acids are able to enhance the expression of the UCP-2 gene, as well as genes like heart-type fatty acid binding protein, acyl-CoA synthetase, mCPT1, or long-chain acyl-CoA dehydrogenase in neonatal cardiomyocytes (35) (36) (37) , suggests a common mechanism. The exact mechanism by which fatty acids modulate UCP-2 expression is, however, unknown. Since fatty acids are able to activate PPARs (12, 13) , these transcription factors may be involved in fatty acid-induced gene expression. Indeed, cardiac expression of the fatty acidresponsive mCPT1 gene has been demonstrated to be regulated by PPAR␣ (37, 38) . When Wy-14,643, a specific activator of PPAR␣, was added to neonatal cardiomyocytes the expression of UCP-2, as well as that of various genes involved in cardiac fatty acid transport and metabolism (36) increased dramatically. In contrast, the PPAR␥-specific ligand ciglitazone, a thiazolidinedione (TZD), did not affect UCP-2 expression. The fact that TZDs are able to enhance UCP-2 expression in a variety of other cell types, including adipocytes and the rat skeletal muscle cell line L6 (39, 40) , most likely reflects differences in the tissue distribution of the corresponding PPARs, with PPAR␥ being abundantly present in adipocytes and virtually absent from cardiomyocytes. The involvement of PPAR in mediating fatty acid responsiveness to the UCP-2 gene is further supported by the observation that 9-cis retinoic acid, the ligand for the retinoid X receptor (which in turn acts as the dimerization partner for PPAR), also enhances UCP-2 expression in cultured brown adipocytes (41) . However, it should be noted that to the best of our knowledge, and unlike UCP-1 (42), a functional PPAR response element has not yet been identified in the UCP-2 gene.
Induction of neonatal myocyte hypertrophy with the ␣ 1 -adrenergic agonist phenylephrine, which is an established model of in vitro hypertrophy (43), did not result in changes in UCP-2 gene expression. This observation corroborates the absence of alterations in UCP-2 mRNA levels in hypertrophied hearts of aorta-banded rats. In contrast, UCP-2 expression increased after enhancing cellular metabolism by the thyroid hormone T3. The current findings are in line with those of Teshima et al. (32) , who reported a stimulatory effect of T3 and ␤-adrenergic agonists, but not of ␣ 1 -adrenergic agonists, on UCP-2 expression in neonatal cardiomyocytes. However, fatty acids are far more potent inducers of UCP-2 expression than either ␤-adrenergic agonists or T3. Furthermore, in our hands the stimulatory effect of T3 depended on the coadministration of fatty acids, which strongly suggests a permissive action of fatty acids to T3-induced UCP-2 expression.
Physiological implications
Taken together, the present findings indicate that the expression of UCP-2 in neonatal hearts, isolated neonatal cardiomyocytes, and embryonic heart-derived H9c2 cells is responsive to changes in the dietary environment, in contrast to its expression in the adult heart. Currently, the mechanism responsible for this difference in behavior is unclear. First, it is striking that PPAR␣ ligands affect UCP-2 expression in neonatal cardiomyocytes but not in the adult rat heart after in vivo administration (44) . This coincides with the effects of PPAR␣ ligands on the expression of proteins involved in fatty acid transport and metabolism. Their expression is increased in neonatal cardiomyocytes after addition of the PPAR␣-specific ligand Wy-14,643 (36) , whereas mRNA levels of fatty acid transport protein and acyl-CoA synthetase are hardly altered after administration of a potent PPAR␣ activator to adult rats (45) . Second, the changes in fatty acid levels in the cellular model systems (0.0 mM vs. 0.5 mM) and during the perinatal development (0.02 to 0.4 mM) (46) are more obvious than those induced by fasting and diabetes (0.3 to 1.5 mM). It is conceivable that maximal stimulation of cardiac UCP-2 expression by fatty acids is already achieved at the relatively high circulating fatty acid levels found in adult rats.
Although UCP-2 is expressed abundantly in the heart, the biological significance of UCP-2 in this tissue is incompletely understood. It has been hypothesized that mitochondrial uncoupling reduces the formation of reactive oxygen species, by-products of mitochondrial oxidation (47, 48) . In this respect, uncoupling by both ADP/ATP translocase and UCP-2 has been demonstrated to mediate this antioxidant effect, as evidenced by their capacity to inhibit mitochondrial formation of H 2 O 2 (47, 49) . Although the uncoupling activity of UCP-1 can be enhanced by fatty acids (50), a direct stimulatory effect of fatty acids on UCP-2 uncoupling activity has not been demonstrated. The fact that fatty acids induce UCP-2 in neonatal cardiomyocytes along with a panel of genes encoding proteins known to be involved in cardiac fatty acid transport and metabolism (36) is indicative of a relationship between UCP-2 and fatty acid handling. The finding that the modulatory effects of fatty acids on UCP-2 gene expression appears to be restricted to neonatal cardiomyocytes and absent in the adult heart is very intriguing and warrants further investigation.
